GR-203040 is a selective NK1 receptor antagonist. GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder. GR203040 is a novel anti-emetic agent, and the broad spectrum of anti-emetic activity, together with activity observed in three species, suggests that this compound is worthy of clinical investigation. References: Gallantine EL, Meert TF. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists. Pharmacol Biochem Behav. 2004 Sep;79(1):125-35. PubMed PMID: 15388292.

纯度：≥98%

CAS：168398-02-5